[go: up one dir, main page]

LU74558A1 - - Google Patents

Info

Publication number
LU74558A1
LU74558A1 LU74558A LU74558A LU74558A1 LU 74558 A1 LU74558 A1 LU 74558A1 LU 74558 A LU74558 A LU 74558A LU 74558 A LU74558 A LU 74558A LU 74558 A1 LU74558 A1 LU 74558A1
Authority
LU
Luxembourg
Application number
LU74558A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority claimed from KR7600645A external-priority patent/KR800001387B1/ko
Publication of LU74558A1 publication Critical patent/LU74558A1/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus

Landscapes

  • Health & Medical Sciences (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
LU74558A 1975-03-17 1976-03-15 LU74558A1 (nl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US55910775A 1975-03-17 1975-03-17
US65800376A 1976-02-13 1976-02-13
KR7600645A KR800001387B1 (en) 1975-03-17 1976-03-16 Process for preparing sustained release formulation

Publications (1)

Publication Number Publication Date
LU74558A1 true LU74558A1 (nl) 1977-09-27

Family

ID=27348140

Family Applications (1)

Application Number Title Priority Date Filing Date
LU74558A LU74558A1 (nl) 1975-03-17 1976-03-15

Country Status (21)

Country Link
JP (1) JPS51115910A (nl)
AR (1) AR222624A1 (nl)
AT (1) AT353415B (nl)
AU (1) AU505355B2 (nl)
CA (1) CA1073358A (nl)
CH (1) CH630257A5 (nl)
DD (1) DD124102A5 (nl)
DE (1) DE2611041A1 (nl)
DK (1) DK148344C (nl)
ES (1) ES446075A1 (nl)
FR (1) FR2304354A1 (nl)
GB (1) GB1546448A (nl)
GR (1) GR60341B (nl)
IE (1) IE43083B1 (nl)
LU (1) LU74558A1 (nl)
MC (1) MC1101A1 (nl)
NL (1) NL190313C (nl)
NZ (1) NZ180321A (nl)
PH (1) PH14927A (nl)
PT (1) PT64907B (nl)
SE (1) SE433804B (nl)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ197543A (en) * 1980-07-02 1984-12-14 Commw Scient Ind Res Org Controlled release compositions for inclusion in intraruminal devices
CH649215A5 (de) * 1981-04-29 1985-05-15 Hoffmann La Roche Pharmazeutische praeparate.
CH652025A5 (de) * 1981-09-14 1985-10-31 Hoffmann La Roche Pharmazeutisches praeparat.
US4421736A (en) * 1982-05-20 1983-12-20 Merrel Dow Pharmaceuticals Inc. Sustained release diethylpropion compositions
GB2154874B (en) * 1984-02-29 1987-11-04 Sandoz Ltd Bromoscriptine compositions
CH666406A5 (de) * 1984-02-29 1988-07-29 Sandoz Ag Verfahren zur herstellung von mikrokapseln, welche bromokriptinmesylat als pharmakologischen wirkstoff enthalten.
JPS61501511A (ja) * 1984-03-21 1986-07-24 アメリカン・ホ−ム・プロダクツ・コ−ポレイション 徐放性医薬カプセル
JPS6143108A (ja) * 1984-08-03 1986-03-01 Nippon Shinyaku Co Ltd 医薬品製剤及びその製造法
NL8600161A (nl) * 1985-02-05 1986-09-01 Sandoz Ag Farmaceutische preparaten die 9,10-dihydroergotalkaloiden bevatten.
GB8524135D0 (en) * 1985-10-01 1985-11-06 Sandoz Ltd Darodipine compositions
HU197201B (en) * 1985-10-01 1989-03-28 Sandoz Ag Process for producing oral pharmaceutical compositions of controlled solubility of the active components
US4786503A (en) * 1987-04-06 1988-11-22 Alza Corporation Dosage form comprising parallel lamine
US4814178A (en) * 1987-07-01 1989-03-21 Sanford Bolton Floating sustained release therapeutic compositions
US5133974A (en) * 1989-05-05 1992-07-28 Kv Pharmaceutical Company Extended release pharmaceutical formulations
IE64128B1 (en) * 1990-02-26 1995-07-12 Byrne Rynne Holdings Ltd A pharmaceutical composition
WO1992013527A1 (en) * 1991-01-30 1992-08-20 The Wellcome Foundation Limited Water-dispersible tablets
US5629016A (en) * 1991-01-30 1997-05-13 Glaxo Wellcome Inc. Water-dispersible tablets
WO1992017166A1 (en) * 1991-04-08 1992-10-15 Nippon Shinyaku Co., Ltd. Capsule
CA2132012C (en) * 1992-03-25 2003-04-22 John W. Shell Alkyl-substituted cellulose-based sustained-release oral drug dosage forms
US5698226A (en) * 1993-07-13 1997-12-16 Glaxo Wellcome Inc. Water-dispersible tablets
US5888540A (en) * 1993-10-29 1999-03-30 Sugden; Keith Pharmaceutical products
JPH09504286A (ja) * 1993-10-29 1997-04-28 レキット アンド コールマン プロダクツ リミテッド 発泡しうるゼラチンカプセル充填物
CA2175225C (en) * 1993-10-29 2004-09-21 Keith Graeme Hutchison Gelatin capsule fill able to foam
CA2190188A1 (en) * 1994-05-13 1995-11-23 Prasad S. Adusumilli Method and composition for increasing calcium uptake
CN1172429A (zh) * 1994-12-01 1998-02-04 希博斯药物公司 使用从高等植物中可得到的粉末状水解胶体树胶的持续释放药物运送体系
FR2820319B3 (fr) * 2001-02-08 2003-12-05 Ellipse Pharmaceuticals Procede de fabrication d'un comprime flottant incluant de l'alfuzosine et comprime obtenu
FR2820318B1 (fr) * 2001-02-08 2005-12-23 Ellipse Pharmaceuticals Procede de fabrication d'un comprime flottant incluant un principe actif et comprime obtenu
EP1245227A1 (en) * 2001-03-31 2002-10-02 Jagotec Ag A pharmaceutical tablet system that floats in the stomach for programmed release of active substance and process of producing buoyant material contained in same
FR2874325B1 (fr) * 2004-08-19 2006-10-20 Sanofi Synthelabo Composition pharmaceutique sous forme de comprime a residence gastrique contenant de l'alfuzosine

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1059624B (de) * 1954-11-11 1959-06-18 Dr Knut Jacobus Sundman Verfahren zur Herstellung von in einer Traegersubstanz dispergierten Arzneien in dosierter Form
JPS5512411B2 (nl) * 1974-03-12 1980-04-02
DE2439538C3 (de) * 1974-08-17 1980-07-17 Ludwig Heumann & Co Gmbh, 8500 Nuernberg Verfahren zur Herstellung von oral zu verabreichenden Arzneimitteln mit verzögerter Wirkungsfreigabe

Also Published As

Publication number Publication date
NL190313C (nl) 1994-01-17
DE2611041C2 (nl) 1988-06-09
NL7602776A (nl) 1976-09-21
FR2304354A1 (fr) 1976-10-15
IE43083B1 (en) 1980-12-17
IE43083L (en) 1976-09-17
DK113676A (da) 1976-09-18
FR2304354B1 (nl) 1979-04-27
DK148344B (da) 1985-06-17
PT64907B (fr) 1978-03-24
GR60341B (en) 1978-05-17
MC1101A1 (fr) 1977-02-04
DK148344C (da) 1985-11-04
SE433804B (sv) 1984-06-18
DD124102A5 (nl) 1977-02-02
JPS638084B2 (nl) 1988-02-19
SE7603325L (sv) 1976-09-18
ES446075A1 (es) 1977-09-16
ATA192276A (de) 1979-04-15
CA1073358A (en) 1980-03-11
AT353415B (de) 1979-11-12
GB1546448A (en) 1979-05-23
JPS51115910A (en) 1976-10-13
AR222624A1 (es) 1981-06-15
DE2611041A1 (de) 1976-10-14
AU1204976A (en) 1977-09-22
NZ180321A (en) 1978-06-20
NL190313B (nl) 1993-08-16
CH630257A5 (en) 1982-06-15
PT64907A (fr) 1976-04-01
PH14927A (en) 1982-01-29
AU505355B2 (en) 1979-11-15

Similar Documents

Publication Publication Date Title
FR2304354B1 (nl)
FR2304893B1 (nl)
FI762703A (nl)
JPS557377Y2 (nl)
FR2310176B1 (nl)
FR2305625B1 (nl)
JPS51111438U (nl)
JPS5235229U (nl)
JPS51138681U (nl)
JPS5348331Y2 (nl)
JPS5717727B2 (nl)
JPS5275762U (nl)
JPS51143580U (nl)
JPS5194787U (nl)
JPS5195383U (nl)
JPS5247299U (nl)
JPS5248200U (nl)
BG21571A1 (nl)
CH602823A5 (nl)
CH596120A5 (nl)
BG22440A1 (nl)
BG22607A1 (nl)
BG22213A1 (nl)
CH592763A5 (nl)
BG21506A1 (nl)